CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • AACR 2022 Recap: T Cells Still On Top, But Make Room for Myeloid Cells

    At the 2022 AACR annual meeting, CRI scientists highlighted a wide scope of cancer immunology advances, and…

    April 14, 2022| Arthur N. Brodsky, PhD
  • Ira Mellman Receives 2022 AACR-CRI Lloyd J. Old Award in Cancer Immunology

    Dr. Ira Mellman, a longtime member of the CRI Scientific Advisory Council, received CRI’s highest scientific career…

    April 1, 2022| Arthur N. Brodsky, PhD
  • Mining the Mysteries of Myeloid Cells with CRI Lloyd J. Old STAR Malay Haldar

    CRI Lloyd J. Old STAR Malay Haldar is exploring the role of dendritic cells and macrophages in…

    March 28, 2022| Arthur N. Brodsky, PhD
  • ASCO18 Update: Immunotherapy Progress in Lung Cancer, New Promise in Ovarian Cancer

    Day 3 of ASCO18 revealed more of immunotherapy’s benefits in lung cancer, especially as a first-line option,…

    June 4, 2018| Arthur N. Brodsky, PhD
  • AACR18 Update: Lloyd J. Old Award, Overcoming Immunotherapy Resistance, and the Importance of Dendritic Cells

    Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and…

    April 18, 2018| Arthur N. Brodsky, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute